Bioreactor Conditioning of Valve Scaffolds Seeded Internally with Adult Stem Cells

다국어 초록 (Multilingual Abstract)

The goal of this study was to test the hypothesis that stem cells, as a response to valve-specific extracellular matrix “niches” and mechanical stimuli, would differentiate into valvular interstitial cells (VICs). Porcine aortic root scaffolds were prepared by decellularization. After verifying that roots exhibited adequate hemodynamics in vitro, we seeded human adipose-derived stem cells (hADSCs) within the interstitium of the cusps and subjected the valves to in vitro pulsatile bioreactor testing in pulmonary pressures and flow conditions. As controls we incubated cell-seeded valves in a rotator device which allowed fluid to flow through the valves ensuring gas and nutrient exchange without subjecting the cusps to significant stress. After 24 days of conditioning, valves were analyzed for cell phenotype using immunohistochemistry for vimentin, alpha-smooth muscle cell actin (SMA) and prolyl-hydroxylase (PHA). Fresh native valves were used as immunohistochemistry controls. Analysis of bioreactor-conditioned valves showed that almost all seeded cells had died and large islands of cell debris were found within each cusp. Remnants of cells were positive for vimentin. Cell seeded controls, which were only rotated slowly to ensure gas and nutrient exchange, maintained about 50% of cells alive; these cells were positive for vimentin and negative for alpha-SMA and PHA, similar to native VICs. These results highlight for the first time the extreme vulnerability of hADSCs to valve-specific mechanical forces and also suggest that careful, progressive mechanical adaptation to valve-specific forces might encourage stem cell differentiation towards the VIC phenotype.

참고문헌 (Reference)

1 Sierad LN, "Toward an endothelial-cell covered mechanical valve; surface re-engineering and bioreactor testing of mechanical heart valves" 1 : 22-34, 2014

2 Rajamannan NM, "The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory" 112 : 2222-2229, 2011

3 Pennel T, "The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models" 35 : 6311-6322, 2014

4 Chester AH, "The living aortic valve: from molecules to function" 2014 : 52-77, 2014

5 Keane TJ, "The host response to allogeneic and xenogeneic biological scaffold materials" 9 : 504-511, 2015

6 Tedder ME, "Stabilized collagen scaffolds for heart valve tissue engineering" 15 : 1257-1268, 2009

7 Colazzo F, "Shear stress and VEGF enhance endothelial differentiation of human adipose-derived stem cells" 32 : 139-149, 2014

8 Chuang TH, "Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts" 15 : 2837-2851, 2009

9 Alexopoulos A, "Pathophysiologic mechanisms of calcific aortic stenosis" 6 : 71-80, 2012

10 Ladich E, "Pathology of calcific aortic stenosis" 7 : 629-642, 2011

11 Schoen FJ, "Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium" 7 : 174-179, 1998

12 Towler DA, "Molecular and cellular aspects of calcific aortic valve disease" 113 : 198-208, 2013

13 Chow JP, "Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol" 34 : 685-695, 2013

14 Colazzo F, "Induction of mesenchymal to endothelial transformation of adipose-derived stem cells" 19 : 736-744, 2010

15 Schoen FJ, "Heart valve tissue engineering: quo vadis?" 22 : 698-705, 2011

16 Simionescu DT, "Form follows function: advances in trilayered structure replication for aortic heart valve tissue engineering" 3 : 179-202, 2012

17 Weiss RM, "Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models" 113 : 209-222, 2013

18 Isenburg JC, "Elastin stabilization for treatment of abdominal aortic aneurysms" 115 : 1729-1737, 2007

19 Sierad LN, "Design and testing of a pulsatile conditioning system for dynamic endothelialization of polyphenol-stabilized tissue engineered heart valves" 1 : 138-153, 2010

20 Badylak SF, "Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response" 42 : 1517-1527, 2014

21 Wirrig EE, "Conserved transcriptional regulatory mechanisms in aortic valve development and disease" 34 : 737-741, 2014

22 Londono R, "Biologic scaffolds for regenerative medicine: mechanisms of in vivo remodeling" 43 : 577-592, 2015

23 Rajamannan NM, "Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation" 20 : 168-176, 2011

24 Mathieu P, "Basic mechanisms of calcific aortic valve disease" 30 : 982-993, 2014

25 Tedder ME, "Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering" 17 : 25-36, 2011

26 Akerström F, "Aortic stenosis: a general overview of clinical, pathophysiological and therapeutic aspects" 11 : 239-250, 2013

27 Schoen FJ, "Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983" 16 : 549-559, 1985

28 Voges I, "Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging" 44 : e272-e279, 2013